All Pathways
NeurologyEmergency

Acute Ischemic Stroke - Neurology Pathway (AHA/ASA 2024)

Acute Ischemic Stroke - Neurology Pathway (AHA/ASA 2024): Acute Stroke Suspected → Activate Stroke Code → CT Head Results → Hemorrhagic Stroke.

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Acute Stroke Suspected

    Sudden neurologic deficit

    1. Warning

      Activate Stroke Code

      TIME IS BRAIN

      • IMMEDIATE ACTIONS:
      • - Note LAST KNOWN WELL (LKW) time
      • - ABCs, IV access, O2 if needed
      • - Point-of-care glucose (rule out hypoglycemia)
      • - NIHSS assessment
      • - STAT CT head (no contrast)
      • - Labs: CBC, BMP, coags, troponin
      • GOAL: Door to CT <25 min
      1. Decision

        CT Head Results

        Hemorrhage vs ischemic

        1. Warning

          Hemorrhagic Stroke

          DIFFERENT MANAGEMENT

          • tPA CONTRAINDICATED
          • Neurosurgery consult
          • BP management (target <140 for ICH)
          • Reverse anticoagulation if applicable
          • Consider EVD if hydrocephalus
          • Follow ICH-specific guidelines
        2. Action

          Ischemic Stroke (No hemorrhage)

          Assess for reperfusion therapy

          • Check TIME from LKW:
          • - <4.5 hours: tPA candidate
          • - <24 hours: Thrombectomy candidate (LVO)
          • Check NIHSS
          • Review contraindications
          1. Decision

            Within tPA Window? (<4.5 hours)

            From last known well

            1. Action

              tPA Contraindications

              Review before giving

              • ABSOLUTE:
              • - Active internal bleeding
              • - Recent intracranial hemorrhage
              • - Intracranial neoplasm, AVM, aneurysm
              • - Recent intracranial/spinal surgery
              • - BP >185/110 despite treatment
              • - Platelets <100,000
              • - INR >1.7 or PTT >40
              • - Current anticoagulation (DOACs <48h)
              • RELATIVE (extended window 3-4.5h):
              • - Age >80
              • - NIHSS >25
              • - Prior stroke + diabetes
              1. Action

                tPA Administration

                Alteplase protocol

                • BEFORE tPA:
                • - BP must be <185/110
                • - Labetalol or nicardipine if needed
                • ALTEPLASE DOSING:
                • - 0.9 mg/kg (MAX 90 mg total)
                • - 10% as IV bolus over 1 min
                • - Remaining 90% infusion over 60 min
                • POST-tPA:
                • - ICU/stroke unit
                • - Neuro checks q15 min
                • - BP <180/105 x 24h
                • - No anticoagulation/antiplatelets x 24h
                • - Repeat CT at 24h or if decline
                1. Action

                  Large Vessel Occlusion (LVO) Assessment

                  For thrombectomy consideration

                  • GET CTA head/neck (or MRA)
                  • LVO LOCATIONS:
                  • - ICA (internal carotid)
                  • - M1/M2 (middle cerebral artery)
                  • - Basilar artery
                  • CLINICAL PREDICTORS:
                  • - NIHSS ≥6
                  • - Gaze deviation
                  • - Hemiplegia
                  • SCREENING SCALES:
                  • - RACE, LAMS, VAN
                  1. Action

                    Mechanical Thrombectomy

                    For LVO within time window

                    • STANDARD WINDOW (0-6 hours):
                    • - LVO confirmed
                    • - NIHSS ≥6
                    • - ASPECTS ≥6
                    • - Pre-stroke mRS 0-1
                    • EXTENDED WINDOW (6-24 hours):
                    • - Based on perfusion imaging
                    • - DAWN or DEFUSE 3 criteria
                    • - Mismatch between core and penumbra
                    • CAN BE GIVEN WITH OR AFTER tPA
                    • Transfer to thrombectomy center if needed
                    1. Action

                      Supportive Care

                      All acute stroke patients

                      • BP MANAGEMENT:
                      • - If no reperfusion: Permissive HTN <220/120
                      • - Post-tPA: <180/105 x 24h
                      • GLUCOSE: 140-180 mg/dL
                      • TEMPERATURE: Avoid hyperthermia
                      • DVT PROPHYLAXIS: SCDs, then heparin
                      • SWALLOW EVALUATION before PO
                      • ASPIRIN: 325mg within 24-48h (if no tPA)
                      • STATIN: High-intensity
                      1. Action

                        Secondary Prevention Workup

                        Determine etiology

                        • IMAGING:
                        • - MRI brain (if not done)
                        • - Carotid imaging (CTA, MRA, or US)
                        • - Echo (TTE ± TEE)
                        • MONITORING:
                        • - Telemetry ≥24h for AF detection
                        • - Extended monitoring if cryptogenic
                        • LABS:
                        • - HbA1c, lipid panel
                        • - Consider hypercoag workup if young
                        1. Outcome

                          Outcomes

                          Prognosis

                          • tPA: 30% more likely to have minimal disability
                          • Thrombectomy: NNT ~3 for functional independence
                          • Time is brain: 1.9M neurons lost per minute
                          • Door to needle goal: <60 min
                          • Door to puncture goal: <90 min

Guideline Source

AHA/ASA Guidelines for Early Management of Acute Ischemic Stroke

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Time-dependent treatment windows
  • Hemorrhagic stroke requires different management
  • Thrombectomy requires specialized center
  • NIHSS may underestimate posterior circulation stroke

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Acute Ischemic Stroke - Neurology Pathway (AHA/ASA 2024)?

The Acute Ischemic Stroke - Neurology Pathway (AHA/ASA 2024) is a emergency clinical algorithm for Neurology. It provides a structured decision tree to guide clinical decision-making, based on AHA/ASA Guidelines for Early Management of Acute Ischemic Stroke.

What guideline is the Acute Ischemic Stroke - Neurology Pathway (AHA/ASA 2024) based on?

This algorithm is based on AHA/ASA Guidelines for Early Management of Acute Ischemic Stroke (DOI: 10.1161/STR.0000000000000211).

What are the limitations of the Acute Ischemic Stroke - Neurology Pathway (AHA/ASA 2024)?

Known limitations include: Time-dependent treatment windows; Hemorrhagic stroke requires different management; Thrombectomy requires specialized center; NIHSS may underestimate posterior circulation stroke. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Acute Ischemic Stroke - Neurology Pathway (AHA/ASA 2024) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free